Physician

Luke Benjamin Fletcher, MD

According to 2025 Medicare claims, Luke Fletcher, MD (NPI: 1770979098) practices hematology/oncology in the Eugene-Springfield, OR market, with the plurality of this provider's patient population coming from Lane, OR. This provider's primary affiliated billing organization is ONCOLOGY ASSOCIATES OF OREGON P C (NPI: 1013989854; TIN: 930746296) and primary practice location at 97401-6036. Fletcher is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Fletcher's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 555 traditional Medicare patients, billed 120,131 HCPCS/CPT codes, and received $2,127,073 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,686 prescription claims across 261 beneficiaries totaling $4,669,092 in drug costs, led by Jakafi (Ruxolitinib Phosphate). Open Payments data shows 21 records totaling $543,029. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,480 to $4,669,092. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.